Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28097159 | 0.92 | TSHR (0.34) | USP2ALDH1A1CNR1CNR2CA12 | |
| SCHEMBL10498218 | 0.87 | ALDH1A1 (0.36) | ALDH1A1TDP1CA12CA1CA2 | |
| SCHEMBL10762236 | 0.86 | LMNA (0.42) | USP2ALDH1A1CNR1CNR2 | |
| SCHEMBL1801332 | 0.86 | LMNA (0.42) | USP2ALDH1A1CNR1CNR2 | |
| SCHEMBL469524 | 0.86 | USP2 (0.50) | USP2ALDH1A1CNR1CNR2LPAR1 | |
| SCHEMBL25304331 | 0.86 | LMNA (0.42) | USP2ALDH1A1CNR1CNR2 | |
| SCHEMBL10761324 | 0.86 | LMNA (0.42) | USP2ALDH1A1CNR1CNR2 | |
| SCHEMBL10758278 | 0.86 | LMNA (0.42) | USP2ALDH1A1CNR1CNR2 | |
| SCHEMBL5707859 | 0.86 | LMNA (0.42) | USP2ALDH1A1CNR1CNR2 | |
| SCHEMBL25304326 | 0.86 | LMNA (0.42) | USP2ALDH1A1CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116727928-A | Soldering flux and preparation method thereof | 乐清市荣兴金属材料有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-116727928-A | Soldering flux and preparation method thereof | 乐清市荣兴金属材料有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-107082742-A | Polyol ethers and the method for preparing them | 陶氏环球技术有限责任公司 | 2017-08-22 | — | — | CN | disclosed |
| US-8829229-B2 | Polyol ethers and process for making them | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-09-09 | — | — | US | disclosed |
| EP-2318346-B1 | POLYOL ETHERS AND PROCESS FOR MAKING THEM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-11-20 | — | — | EP | disclosed |
| WO-2011106194-A2 | PROCESS FOR MAKING POLYOL ETHERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-09-01 | — | — | WO | disclosed |
| US-20110207969-A1 | PROCESS FOR MAKING POLYOL ETHERS | DOW GLOBAL TECHNOLOGIES LLC | 2011-08-25 | — | — | US | disclosed |
| EP-2318346-A1 | POLYOL ETHERS AND PROCESS FOR MAKING THEM | Dow Global Technologies LLC (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010027663-A1 | POLYOL ETHERS AND PROCESS FOR MAKING THEM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-03-11 | — | — | WO | disclosed |
| US-20100048940-A1 | reductive etherification of a polyol with an aldehyde or ketone using a hydrogenation catalyt; resulting compounds have use as solvents, surfactants, degreasers, wetting agents, emulsifying agents, lubricants, and intermediates for surfactants; polyols can be from renewable raw materials | DOW GLOBAL TECHNOLOGIES LLC | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207969-A1 | PROCESS FOR MAKING POLYOL ETHERS | PUF60, PARG, PCBP1 | USP2 989/4885ALDH1A1 3977/4885TDP1 4209/4885 |
| US-20100048940-A1 | reductive etherification of a polyol with an aldehyde or ketone using a hydrogenation catalyt; resulting compounds have use as solvents, surfactants, degreasers, wetting agents, emulsifying agents, lubricants, and intermediates for surfactants; polyols can be from renewable raw materials | RNF114, USP14, USP13 | USP2 70/4885ALDH1A1 692/4885TDP1 1846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.